drugset / Trial / NCT07166666
Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)
RandomizedParallel-groupTriple-blindHealth-services research
Summary
To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.
Timeline
- Start
- 2025-09-01
- Primary completion
- 2026-09-30
- Completion
- 2026-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | — | Intranasal |
| Subject | Fentanyl | Other / unclassified | — | Intranasal |
| Subject | Midazolam | Small molecule | — | Intranasal |
Indications
No indication recorded.